581 related articles for article (PubMed ID: 16406828)
1. Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it.
Begriche K; Igoudjil A; Pessayre D; Fromenty B
Mitochondrion; 2006 Feb; 6(1):1-28. PubMed ID: 16406828
[TBL] [Abstract][Full Text] [Related]
2. The ins and outs of mitochondrial dysfunction in NASH.
Fromenty B; Robin MA; Igoudjil A; Mansouri A; Pessayre D
Diabetes Metab; 2004 Apr; 30(2):121-38. PubMed ID: 15223984
[TBL] [Abstract][Full Text] [Related]
3. Etiopathogenesis of nonalcoholic steatohepatitis.
Chitturi S; Farrell GC
Semin Liver Dis; 2001; 21(1):27-41. PubMed ID: 11296694
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic steatosis and steatohepatitis. V. Mitochondrial dysfunction in steatohepatitis.
Pessayre D; Mansouri A; Fromenty B
Am J Physiol Gastrointest Liver Physiol; 2002 Feb; 282(2):G193-9. PubMed ID: 11804839
[TBL] [Abstract][Full Text] [Related]
5. Role of mitochondria in non-alcoholic fatty liver disease.
Pessayre D
J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S20-7. PubMed ID: 17567459
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial injury in steatohepatitis.
Pessayre D; Fromenty B; Mansouri A
Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1095-105. PubMed ID: 15489566
[TBL] [Abstract][Full Text] [Related]
7. From fatty liver to fibrosis: a tale of "second hit".
Basaranoglu M; Basaranoglu G; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1158-65. PubMed ID: 23483818
[TBL] [Abstract][Full Text] [Related]
8. Exercise as a therapeutic tool to prevent mitochondrial degeneration in nonalcoholic steatohepatitis.
Gonçalves IO; Oliveira PJ; Ascensão A; Magalhães J
Eur J Clin Invest; 2013 Nov; 43(11):1184-94. PubMed ID: 24033085
[TBL] [Abstract][Full Text] [Related]
9. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
[TBL] [Abstract][Full Text] [Related]
10. Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease.
Oliveira CP; Coelho AM; Barbeiro HV; Lima VM; Soriano F; Ribeiro C; Molan NA; Alves VA; Souza HP; Machado MC; Carrilho FJ
Braz J Med Biol Res; 2006 Feb; 39(2):189-94. PubMed ID: 16470305
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver.
Begriche K; Massart J; Robin MA; Borgne-Sanchez A; Fromenty B
J Hepatol; 2011 Apr; 54(4):773-94. PubMed ID: 21145849
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial involvement in non-alcoholic steatohepatitis.
Serviddio G; Sastre J; Bellanti F; Viña J; Vendemiale G; Altomare E
Mol Aspects Med; 2008; 29(1-2):22-35. PubMed ID: 18061659
[TBL] [Abstract][Full Text] [Related]
13. Roux-en-y gastric bypass attenuates hepatic mitochondrial dysfunction in mice with non-alcoholic steatohepatitis.
Verbeek J; Lannoo M; Pirinen E; Ryu D; Spincemaille P; Vander Elst I; Windmolders P; Thevissen K; Cammue BP; van Pelt J; Fransis S; Van Eyken P; Ceuterick-De Groote C; Van Veldhoven PP; Bedossa P; Nevens F; Auwerx J; Cassiman D
Gut; 2015 Apr; 64(4):673-83. PubMed ID: 24917551
[TBL] [Abstract][Full Text] [Related]
14. Mitochondria in steatohepatitis.
Pessayre D; Berson A; Fromenty B; Mansouri A
Semin Liver Dis; 2001; 21(1):57-69. PubMed ID: 11296697
[TBL] [Abstract][Full Text] [Related]
15. Hepatotoxicity due to mitochondrial dysfunction.
Pessayre D; Mansouri A; Haouzi D; Fromenty B
Cell Biol Toxicol; 1999; 15(6):367-73. PubMed ID: 10811531
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis.
Schröder T; Kucharczyk D; Bär F; Pagel R; Derer S; Jendrek ST; Sünderhauf A; Brethack AK; Hirose M; Möller S; Künstner A; Bischof J; Weyers I; Heeren J; Koczan D; Schmid SM; Divanovic S; Giles DA; Adamski J; Fellermann K; Lehnert H; Köhl J; Ibrahim S; Sina C
Mol Metab; 2016 Apr; 5(4):283-295. PubMed ID: 27069868
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial dysfunction in nonalcoholic steatohepatitis.
Serviddio G; Bellanti F; Vendemiale G; Altomare E
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):233-44. PubMed ID: 21476918
[TBL] [Abstract][Full Text] [Related]
18. [Role of oxidative stress in non-alcoholic steatohepatitis].
Mitsuyoshi H; Itoh Y; Okanoue T
Nihon Rinsho; 2006 Jun; 64(6):1077-82. PubMed ID: 16768112
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial adaptations and dysfunctions in nonalcoholic fatty liver disease.
Begriche K; Massart J; Robin MA; Bonnet F; Fromenty B
Hepatology; 2013 Oct; 58(4):1497-507. PubMed ID: 23299992
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases.
Mansouri A; Gattolliat CH; Asselah T
Gastroenterology; 2018 Sep; 155(3):629-647. PubMed ID: 30012333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
